Literature DB >> 1026548

The effect of forewarning on the occurrence of side-effects and discontinuance of medication in patients on dothiepin.

E D Myers, E J Calvert.   

Abstract

Dothiepin was prescribed for 100 depressed out-patients alternately allocated to one of two groups. Patients in Group A were forewarned about side-effects and patients in Group B were not forewarned. None of the patients had previously received dothiepin. After two weeks the patients were questioned regarding side-effects and continuance with medication. Eighty-nine patients were included in the final analysis. The results failed to confirm the hypotheses that forewarning patients of side-effects causes a greater number of patients to complain of such effects, or that where patients experience side-effects, forewarning is associated with any less frequent discontinuance of therapy. Compared with a previous study with amitriptyline, the results of this study are much closer to statistical significance. This may be due to the lower overall incidence of side-effects with dothiepin and calls for further work with a larger sample of patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026548     DOI: 10.1177/030006057600400405

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  11 in total

Review 1.  The impact of informing psychiatric patients about their medication: a systematic review.

Authors:  Franciska A M Desplenter; Steven Simoens; Gert Laekeman
Journal:  Pharm World Sci       Date:  2007-01-10

2.  Patient package inserts.

Authors:  E D Myers; E J Calvert
Journal:  Br Med J       Date:  1978-10-07

3.  The benefits of prescription information leaflets (1).

Authors:  S Gibbs; W E Waters; C F George
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

4.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

5.  Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.

Authors:  Janet Krska; Charles W Morecroft
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

6.  Informing patients about drug side effects.

Authors:  L A Morris; D E Kanouse
Journal:  J Behav Med       Date:  1982-09

7.  Prescription information leaflets: a national survey.

Authors:  S Gibbs; W E Waters; C F George
Journal:  J R Soc Med       Date:  1990-05       Impact factor: 18.000

8.  Effectiveness and cost-effectiveness of a multicomponent intervention to improve medication adherence in people with depressive disorders - MAPDep: a study protocol for a cluster randomized controlled trial.

Authors:  Tasmania Del Pino-Sedeño; Wenceslao Peñate; Carlos de Las Cuevas; Cristina Valcarcel-Nazco; Ascensión Fumero; Pedro Guillermo Serrano-Pérez; Francisco Javier Acosta Artiles; Vanesa Ramos García; Beatriz León Salas; Daniel Bejarano-Quisoboni; María M Trujillo-Martín
Journal:  Patient Prefer Adherence       Date:  2019-02-22       Impact factor: 2.711

Review 9.  Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice.

Authors:  Nikolaos Kyriakos; Apostolis Papaefthymiou; Marios Giakoumis; George Iatropoulos; Gerasimos Mantzaris; Christos Liatsos
Journal:  Ann Gastroenterol       Date:  2021-06-03

10.  Structural equation modeling of the proximal-distal continuum of adherence drivers.

Authors:  Colleen A McHorney; Ning Jackie Zhang; Timothy Stump; Xiaoquan Zhao
Journal:  Patient Prefer Adherence       Date:  2012-11-09       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.